What could cause an elevated gamma‑glutamyl transferase (GGT) of 122 U/L with ferritin 900 ng/mL, mildly increased alanine aminotransferase (ALT) of 64 U/L, normal aspartate aminotransferase (AST), normal alkaline phosphatase, and normal serum iron (86 µg/dL), and what diagnostic work‑up is recommended?

Elevated GGT with High Ferritin: Likely Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with Iron Overload

Your patient most likely has MASLD (formerly NAFLD) with secondary iron overload, and you should immediately assess for metabolic syndrome components, calculate a FIB-4 or NAFLD Fibrosis Score, and test for hemochromatosis with transferrin saturation. 1

Primary Diagnostic Considerations

The pattern of mildly elevated ALT (64 U/L), elevated GGT (122 U/L), and markedly elevated ferritin (900 ng/mL) with normal iron and alkaline phosphatase strongly suggests:

1. MASLD as the Primary Driver

• GGT elevation is strongly associated with hepatic steatosis, metabolic syndrome, and fibrosis in MASLD patients 2
• The ALT elevation (64 U/L) combined with GGT elevation creates a significantly increased odds ratio (4.17×) for metabolic syndrome compared to normal values 2
• GGT is a superior early marker for metabolic dysfunction, atherosclerosis, and future disease risk compared to other liver enzymes 3

2. Secondary Iron Overload (Not Primary Hemochromatosis)

• The normal serum iron (86 µg/dL) with elevated ferritin argues against primary hemochromatosis, where you would expect elevated transferrin saturation as the first abnormality 4
• Ferritin at 900 ng/mL represents inflammatory/metabolic iron dysregulation rather than true iron overload
• However, you must still check transferrin saturation to definitively exclude hemochromatosis 4

Immediate Workup Algorithm

Step 1: Assess for Metabolic Syndrome Components

Look specifically for:

• BMI >25 (obesity doubles liver disease risk at any alcohol intake) 1
• Type 2 diabetes or impaired glucose tolerance
• Hypertension
• Dyslipidemia (particularly elevated triglycerides and low HDL, which correlate with GGT) 5, 6

Step 2: Quantify Alcohol Intake

• Use AUDIT-C screening followed by full 10-item AUDIT if positive 1
• Even moderate alcohol should be discouraged with iron overload and liver abnormalities 4
• GGT >48 U/L (men) or >75 U/L (women) exceeds updated reference limits and predicts adverse outcomes 7

Step 3: Calculate Fibrosis Risk

First-line: Calculate FIB-4 or NAFLD Fibrosis Score immediately 1

• If intermediate or high risk → proceed to second-line testing
• Second-line: Obtain FibroScan/ARFI elastography or serum ELF 1

Step 4: Iron Studies to Exclude Hemochromatosis

Order:

• Transferrin saturation (calculated from serum iron and TIBC)
• If transferrin saturation >45% (women) or >50% (men), proceed to HFE genotyping for p.C282Y 4
• Your patient's normal iron makes this less likely, but ferritin >200 µg/L (women) or >300 µg/L (men) with elevated transferrin saturation mandates genetic testing 4

Step 5: Exclude Drug-Induced Liver Injury

• Review all medications and supplements
• GGT elevation >2× ULN (which your patient has at 122 U/L) can indicate DILI even without meeting conventional ALT thresholds 8
• Consider RUCAM scoring if hepatotoxic drug exposure identified

Critical Pitfalls to Avoid

1. Don't dismiss the ferritin elevation as purely inflammatory without checking transferrin saturation—you could miss early hemochromatosis where treatment (phlebotomy) prevents cirrhosis 4

2. Don't ignore GGT because ALT is only mildly elevated—GGT is actually a stronger predictor of hepatic fibrosis and metabolic disease than ALT in MASLD 2, 7

3. Don't assume normal alkaline phosphatase rules out significant liver disease—the mixed pattern (elevated GGT and ALT with normal ALP) is classic for MASLD 1

4. Avoid raw seafood and limit alcohol strictly if iron overload confirmed—Vibrio vulnificus causes >50% mortality in hemochromatosis patients with sepsis 4

When to Refer to Hepatology

Refer if:

• FIB-4 or NFS indicates intermediate/high fibrosis risk
• Transferrin saturation elevated with ferritin >200-300 µg/L
• Persistent elevation despite lifestyle modification
• Any patient with abnormal liver tests and negative extended workup should be discussed with hepatology 1

Prognostic Significance

Your patient's GGT at 122 U/L (>2.5× the updated reference limit of 48 U/L for men) predicts:

• Increased cardiovascular mortality risk 9
• Higher likelihood of metabolic syndrome progression 3
• AST >2× ULN carries >5% 10-year risk of major adverse liver outcomes, though your patient's AST is currently normal 7